Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary ApproachTae-Han Kim, Baek‐hui Kim, Bang Wool Eom et al.|Journal of the Korean Gastric Cancer Association|2023Cited by 285
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)In‐Ho Kim, Seung Joo Kang, Wonyoung Choi et al.|Journal of the Korean Gastric Cancer Association|2025Cited by 96
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trialHyung‐Don Kim, Changhoon Yoo|Nature Medicine|2024Cited by 65